TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Vera Therapeutics
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

Vera Therapeutics plans to raise approximately $261 million through a public offering of 6,138,108 shares of Class A common stock at $42.50 per share, with underwriters led by J.P. Morgan and Goldman Sachs.

Insights
VERA   neutral

The company is conducting a standard public stock offering to raise capital for potential future development, which is a typical financial strategy for biotechnology firms